DRUG AND MEDICAL DEVICE LITIGATION

Advancements in medical science have provided new effective medications and medical devices that have provided positive benefits to scores of Americans.  Too often however, new drugs and devices are rushed to market by large drug and medical device companies without appropriate study and testing.  This "rush to market" of each new potentially beneficial drug or device prior to adequate study, review and testing has harmed millions of Americans and puts all medical patients at risk while drug companies reap enormous profits from marketing the latest "miracle drug."

There are a number of excellent and publicly available resources to locate information about potentially harmful drugs and devices.  The firm has prosecuted numerous lawsuits against pharmaceutical companies and routinely reviews new cases.

Worst Pills by Public Citizen

U.S. Food and Drug Administration

MEDWATCH

WebMD

MedicineNet

Disability Info Gov

Health Dangers

Medical Device Link

Public Citizen - The Health Research Group

Center for Drug Evaluation and Research

BAYCOL LITIGATION LINKS
Bayer withdraws Baycol from Market
FDA Approval History of Baycol
Letter to Health Care Professionals regarding Baycol
Baycol Label Insert

SERZONE LITIGATION LINKS
FDA Alert & Patient Information 7-2005
FDA Public Health Advisory
Class suicideality labeling language for Antidepressants
Serzone & Liver Failure: Important Drug Warning & Black Box Information

VIOXX LITIGATION LINKS
FDA Issues Public Health Advisory & Withdraws Vioxx
Letter to Health Care Professionals regarding Vioxx
Merck found Liable in Vioxx Case

MEDTRONIC DEFIBRILLATOR LITIGATION
Recall Notice for Medtronic Defibrillator
Lessons from the failure & recall of an Implantable Cardioverter Defibrillator
Medtronic List of Affected Device Serial Numbers
FDA Update for Guidant Implantable Cardioverter Defibrillators

BAXTER- MERIDIAN HEMODIALYSIS
Baxter Urgent Product Recall
FDA Recall Meridian Hemodialysis Instrument
Five Kidney Dialysis Deaths Prompt Baxter/FDA  Action 9-12-02
FDA Classification to Baxter Recall for Meridian Hemodialysis Instrument
FDA Notifies Health Care Professionals of Problem with Baxter-Meridian Hemodialysis Instrument

The firm operates on a contingency fee basis. The initial consultation is completely free of charge. No recovery, No fee.